Dr Muhammad Mohiuddin

Dr Mohiuddin received his MBBS (MD) degree from Dow Medical College in Karachi, and after completing his surgical training at Civil Hospital Karachi, he moved to the United States where he completed his first fellowship in Transplantation Biology at University of Pennsylvania (Verdi DiSesa) and later fellowship in bone marrow transplantation at Institute of Cellular Therapeutics (Suzanne Ildstad), MCP Hahnemann University (now Drexel University).
Currently, he is a Professor of Surgery and the Director of the Cardiac Xenotransplantation Program at the University of Maryland School of Medicine. Prior to joining the faculty there, he was the chief of the transplantation section of the Cardiothoracic Surgery Research Program and Senior Scientist at the National Heart Lung and Blood Institute of the National Institutes of Health. He has been involved in the field of xenotransplantation for over 30 years and has held faculty positions at the University of Pennsylvania and Rush University.
Dr Mohiuddin’s primary interest is in understanding the role of B lymphocytes in transplantation, especially xenograft rejection. His other interests include transplantation tolerance and immune modulation. He has made several contributions to the fields of transplantation and xenotransplantation with over 120 publications and over 100 abstracts as well as numerous presentations. His group holds the record of longest xenograft survival in a large animal model. The immunosuppressive regimen developed under his leadership is now used widely throughout the xenotransplantation field.
Dr Mohiuddin is an elected councilor of International Xenotransplantation Association. He is a member of prestigious societies; The Transplantation Society and American Society of Transplant Physicians. He reviews manuscripts for journals; Transplantation, Transplant Immunology, xenotransplantation, Journal of Heart and Lung Transplantation, etc. He has received several NIH and non-NIH grants during his academic career. His recent work in cardiac xenotransplantation was highlighted widely in press throughout the world.